Literature DB >> 6872412

Furosemide kinetics and dynamics in aged patients.

A L Kerremans, Y Tan, H van Baars, C A van Ginneken, F W Gribnau.   

Abstract

Furosemide (F) is frequently used by elderly persons. We wanted to know whether age-related changes in the disposition or the effect of F occurred and whether these changes could be predicted or explained. Kinetics and diuretic effects were studied after intravenous F injection in geriatric patients (70 to 93 yr of age). The changes in kinetics were as follows: slightly enlarged volume of distribution (0.16 +/- 0.04 l) inversely related to serum albumin, diminished total body clearance (73 +/- 27 ml/min), decreased renal clearance (40 +/- 18 ml/min), and prolonged elimination t1/2 (180 +/- 87 min). F effects were unchanged only if the decreased renal delivery of F and the decreased glomerular filtration rate were taken into account. Renal F clearance correlated best with endogenous creatinine clearance (ECC) and with F effects. Only ECC and plasma creatinine turned out to be useful patient characteristics to predict all F effects. Many drugs have an increased effect in elderly persons if a standard dose is used, based on the attainment of higher free plasma levels. In the case of F, however, the effects are decreased because they depend on decreased glomerular filtration of electrolytes and water and on decreased renal F secretion. These decreases are in part age dependent and in part disease dependent.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6872412     DOI: 10.1038/clpt.1983.150

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  15 in total

Review 1.  Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications.

Authors:  A A Mangoni; S H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

Review 2.  Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part II).

Authors:  L L Ponto; R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

3.  Plasma protein binding of furosemide in the elderly.

Authors:  G M Pacifici; A Viani; H U Schulz; H J Frercks
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 4.  Resistance to loop diuretics. Why it happens and what to do about it.

Authors:  D C Brater
Journal:  Drugs       Date:  1985-11       Impact factor: 9.546

Review 5.  Diuretic drugs. Progress in clinical pharmacology.

Authors:  A Lant
Journal:  Drugs       Date:  1986       Impact factor: 9.546

6.  Urinary excretion and diuretic action of furosemide in rats: increased response to the urinary excretion rate of furosemide in rats with acute renal failure.

Authors:  T Kikkoji; A Kamiya; K Inui; R Hori
Journal:  Pharm Res       Date:  1988-11       Impact factor: 4.200

7.  A quantitative method of evaluating the diuretic response to furosemide in rats.

Authors:  R Hori; K Okumura; K Inui; T Shibata; T Kikkoji; A Kamiya
Journal:  Pharm Res       Date:  1988-11       Impact factor: 4.200

Review 8.  Clinical pharmacokinetic considerations in the treatment of increased intracranial pressure.

Authors:  G Heinemeyer
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

Review 9.  Benefits and risks of torasemide in congestive heart failure and essential hypertension.

Authors:  D C Brater
Journal:  Drug Saf       Date:  1996-02       Impact factor: 5.606

Review 10.  Physiological changes due to age. Implications for drug therapy of congestive heart failure.

Authors:  R J Cody
Journal:  Drugs Aging       Date:  1993 Jul-Aug       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.